Emerging Antiarrhythmic Drugs for Atrial Fibrillation

Atrial fibrillation (AF), the most common cardiac arrhythmia worldwide, is driven by complex mechanisms that differ between subgroups of patients. This complexity is apparent from the different forms in which AF presents itself (post-operative, paroxysmal and persistent), each with heterogeneous pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saljic, Arnela, Heijman, Jordi, Dobrev, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029767/
https://www.ncbi.nlm.nih.gov/pubmed/35456912
http://dx.doi.org/10.3390/ijms23084096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029767/
https://www.ncbi.nlm.nih.gov/pubmed/35456912
http://dx.doi.org/10.3390/ijms23084096

Ejemplares similares